Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incretin-based therapy in preclinical type 1 diabetes in adults
2014-003667-37Phase 2Completed
- Sponsor
- Riitta Veijola
- Start
- Nov 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of liraglutide in diabetes mellitus type 1 (T1D), sponsored by Riitta Veijola. Primary endpoints: Insulin secretion, Glucose metabolism and 1 more. Started Nov 2015; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-003667-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003667-37.